🎗️ AI-Assisted System Could Revolutionize Early Cancer Detection

An innovative AI-assisted system accelerates cancer detection by automating cell examination, which was previously a manual and time-consuming task. This advancement may enhance diagnostic accuracy and speed, potentially impacting healthcare systems worldwide through earlier disease identification techniques and leveraging machine learning algorithms.

Read More:

Gamma: $68 Million At $2.1 Billion Valuation Raised As It Surpasses $100 Million In ARR

Gamma announced that it has raised $68 million in Series B funding at a valuation of $2.1 billion. Andreessen Horowitz led the round with participation from Accel, Uncork Capital, and other existing investors. The company also revealed that it has surpassed $100 million in annual recurring revenue. This financing includes a secondary component to provide liquidity to early employees, reflecting the founders’ intent to share the company’s success with the team members who helped build it.

Investing in Gamma

As a recovering consultant, I’ve spent more hours than I’d like to admit nudging text boxes in PowerPoint and wrestling with think-cell charts (the first application I requested to purchase when I arrived at a16z almost 7 years ago). I still have muscle memory for PowerPoint shortcuts, the flashbacks of drawing waterfall bridges at 2…